Free Trial
Notice: An IPO for SNYR is planned for Friday, October 4, 2024

Synergy CHC Corp. (Uplisting) (SNYR) Competitors

$4.05
+1.67 (+70.17%)
(As of 10/1/2024 ET)

SNYR vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, ACABU, BFRIW, BTMDW, and BCTXW

Should you be buying Synergy CHC Corp. (Uplisting) stock or one of its competitors? The main competitors of Synergy CHC Corp. (Uplisting) include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Synergy CHC Corp. (Uplisting) vs.

Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability, institutional ownership and community ranking.

In the previous week, 180 Life Sciences had 2 more articles in the media than Synergy CHC Corp. (Uplisting). MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for Synergy CHC Corp. (Uplisting). 180 Life Sciences' average media sentiment score of 1.29 beat Synergy CHC Corp. (Uplisting)'s score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Synergy CHC Corp. (Uplisting) Neutral
180 Life Sciences Positive

Synergy CHC Corp. (Uplisting) and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Synergy CHC Corp. (Uplisting)N/AN/A
180 Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
Synergy CHC Corp. (Uplisting)N/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synergy CHC Corp. (Uplisting)N/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synergy CHC Corp. (Uplisting)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

180 Life Sciences beats Synergy CHC Corp. (Uplisting) on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNYR vs. The Competition

MetricSynergy CHC Corp. (Uplisting)Medical Distribution IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.65B$5.53B$8.45B
Dividend YieldN/A1.29%4.48%4.09%
P/E RatioN/A108.36139.2718.54
Price / SalesN/A119.671,647.9784.73
Price / CashN/A10.8737.8033.65
Price / BookN/A2.134.834.52
Net IncomeN/A$45.17M$114.66M$225.45M
7 Day PerformanceN/A10.85%3.98%2.40%
1 Month PerformanceN/A2.41%10.53%6.11%
1 Year PerformanceN/A-8.00%23.33%17.74%

Synergy CHC Corp. (Uplisting) Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNYR
Synergy CHC Corp. (Uplisting)
N/A$4.05
+70.2%
N/AN/A$0.00N/A0.0040Gap Up
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-32.5%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
flat
N/A-67.6%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$65,122.000.0040Gap Down
ALVOW
Alvotech
N/A$2.62
flat
N/AN/A$0.00$306.77M0.004
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/A-42.5%$0.00N/A0.004Positive News
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$11.50
flat
N/AN/A$0.00N/A0.004Positive News
BFRIW
Biofrontera
N/A$0.03
flat
N/AN/A$0.00$35.24M0.0070Positive News
BTMDW
biote
N/A$0.52
+4.0%
N/A-51.4%$0.00$187.23M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.41
+24.2%
N/A-87.4%$0.00N/A0.008Positive News
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SNYR) was last updated on 10/2/2024 by MarketBeat.com Staff
From Our Partners